This may also have underestimated the SDFR prevalence in both the ACPA-negative and ACPA-positive RA patients and might have resulted in an underestimation of the observed effect between the SDFR and non-SDFR groups. The gene discussed is PRTN3; the disease is rheumatoid arthritis.